Search clinical trials for: Pioglitazone and sulphonylurea

Total 272134 results

University of Texas Southwestern Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Takeda...

Recruiting

Pathophysiology of Uric Acid Nephrolithiasis (IUAN)

Uric Acid Kidney Stone Disease

United States
Takeda

Completed

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Diabetes Mellitus | Liver
University of Rome Tor Vergata

Unknown

PIoglitazone for PrEvention of Restenosis in Diabetic Patients

Diabetes | Coronary Atherosclerosis | Coronary Restenosis

Italy
Takeda

Completed

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
French National Agency for Research on AIDS and...

Terminated

Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance (PEGLIST C)

Insulin Resistance | Chronic Hepatitis C

France
Sanofi

Completed

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA) (GETGOAL-L-ASIA)

Diabetes Mellitus, Type 2

Philippines, Taiwan, Japan, Korea, Republic of
Pfizer

Completed

Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)

Healthy

United States
Boehringer Ingelheim

Completed

Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers

Healthy
Janssen Research & Development, LLC

Completed

A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants

Healthy Volunteers

Belgium
Sanofi

Completed

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea (GETGOAL-S)

Diabetes Mellitus, Type 2

United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
Bayside Health
The Alfred; Baker Heart and Diabetes Institute

Unknown

Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment

Obesity | Cardiovascular Disease | Type 2 Diabetes

Australia
Brooke Army Medical Center

Completed

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Hepatitis c

United States
Sun Yat-sen University

Unknown

Effects of Different Early Intensive Therapies on Long-term β-cell Function

Diabetes Mellitus, Type 2
Kun-Ho Yoon
Takeda

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea (PEAK)

Type 2 Diabetes Mellitus

Korea, Republic of
Tehran University of Medical Sciences

Completed

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

Uncontrolled Type 2 Diabetes Mellitus

Iran, Islamic Republic of
AstraZeneca

Completed

A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Diabetes

United States, Mexico, Argentina, Brazil, Puerto Rico, Russian Federation, Germany, Italy, Ukraine, India, Hungary, Poland, Philippines
Postgraduate Institute of Medical Education and...

Completed

Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis

Psoriasis

India
University of Texas Southwestern Medical Center

Completed

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Tufts Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Metabolic Abnormalities in HIV-infected Persons

HIV Infection | Lipodystrophy

United States
Command Hospital, India

Unknown

A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease (GLAZED)

Fatty Liver

India
Lawson Health Research Institute
University of Western Ontario, Canada; Academic Medical Organization of Southwestern...

Completed

Vaginal Estrogen With Pessary Treatment

Quality of Life | Urinary Tract Infection | Vaginal Infection

Canada
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
GlaxoSmithKline

Terminated

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

Infections, Intestinal

United States, Czechia, Russian Federation, Spain, Canada, France, Italy
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Insulin Regulation of Lipolysis and Lipolysis Proteins

Obesity

United States
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI); Pharmaxis

Completed

Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN

Asthma

United States
Austin Health

Completed

A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) Patients (MERO001)

Sepsis

Australia
Takeda

Completed

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. (COMPLEMENT)

Diabetes Mellitus

United States, Puerto Rico
University Hospital, Geneva
University of Lausanne Hospitals

Completed

Renal and Hormonal Effects of Pioglitazone

Hypertension | Diabetes

Switzerland
Merck Sharp & Dohme LLC

Completed

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Takeda

Completed

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Type 2 Diabetes Mellitus

United States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
Hospital Universitari Vall d'Hebron Research Institute

Unknown

The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) (EGLIPA)

Diabetes Mellitus Type 2

Spain
Takeda

Terminated

Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2
Assistance Publique - Hôpitaux de Paris

Completed

Effect of GLP-1 on Angiogenesis (ANGIOSAFE 1)

Type 2 Diabetes

France
Coordinación de Investigación en Salud, Mexico

Completed

Pioglitazone and Metformin in Diabetic Children

Type 2 Diabetes

Mexico
Takeda

Terminated

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Diabetes Mellitus, Type 2

China, Hong Kong
Merck Sharp & Dohme LLC

Completed

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

Diabetes Mellitus, Type 2
AstraZeneca

Completed

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Diabetes Mellitus, Type 2

United States, Argentina, Canada, Puerto Rico, Mexico, Philippines, India, Peru
The University of Texas Health Science Center,...

Terminated

Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)

Alcohol Use Disorder

United States
US Department of Veterans Affairs

Completed

Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance

Glucose Metabolism Disorders | Diabetes

United States
Takeda

Completed

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Diabetes Mellitus

Netherlands, Sweden
University of Dhaka
University of Dundee; Bangladesh Institute of Research and Rehabilitation in...

Completed

Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects (T2DMCT)

Type 2 Diabetes Mellitus

Bangladesh
Versailles Hospital

Recruiting

Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) (ACTIW)

Leukemia, Myeloid, Chronic-Phase

France
Govind Ballabh Pant Hospital

Unknown

Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH) (NASH)

Metabolic Parameters and Liver Histology

India
The University of Texas Health Science Center,...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Effects of Pioglitazone on Stress Reactivity and Alcohol Craving

Alcohol Use Disorder

United States
Emory University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Terminated

A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study) (APPEAL)

Alcoholism

United States
National Institute on Drug Abuse (NIDA)

Terminated

Pioglitazone to Treat Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Omeros Corporation

Terminated

Pioglitazone for Heroin and for Nicotine Dependence

Heroin Dependence | Nicotine Dependence

United States
Mayo Clinic

Terminated

Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function

Chronic Kidney Disease

United States
Janssen Research & Development, LLC

Completed

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Diabetes Mellitus, Type 2

United States, United Kingdom, Belgium, Spain, Israel, Mexico, Australia, Russian Federation, Hungary, France, Guatemala, Puerto Rico
University of Milan

Recruiting

Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus (Sulfa-Zero)

Albuminuria | Renal Function Disorder | Diet, Healthy | T2DM (Type 2 Diabetes Mellitus)

Italy

Search clinical trials for: Pioglitazone and sulphonylurea

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations